← Leaderboards
Casey A Maguire
Massachusetts General Hospital
$2,661,741
Attributed
$3,501,741
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $790.6K · FY2012–23$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,501,741 · 4
By mechanism
R01$1,792,953 · 1
R61$840,000 · 1
R21$448,788 · 1
R33$420,000 · 1
Top collaborators
- Xandra Owens Breakefield3 shared
- Vijaya Ramesh3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Khalid A Shah$15,720,802
- David P Corey$15,311,397
- Xandra Owens Breakefield$30,735,276
- Miguel S Esteves$8,755,816
- En Li$2,750,799
Others in their field
Top investigators on “Adeno-Associated Viral Vector”
- Randall J Bateman · Washington University$63,044,576
- Jeffrey S Chamberlain · University Of Michigan At Ann Arbor$36,655,814
- Michael R. Farzan · Boston Children'S Hospital$33,579,607
- Mark A Kay · Stanford University$25,012,385
- Aravind Asokan · Duke University$24,742,088
- Beverly L Davidson · University Of Iowa$19,750,165
Research focus
Adeno-Associated Viral VectorVectorDependovirusLiverCellsGene TherapyMeasurementKnockout MiceCell TypeSerotypingClinically RelevantBindingPropertyMouse ModelToxic EffectBirthDoseClinical TrialsEnsureInjectionsRodentMediatingMembraneCapsid
Grant awards (10)
Enhanced gene delivery for CNS and sensory disorders$356,163
R01 · FY2023 · DC · contact PI
Gene therapy for Tuberous Sclerosis$420,000
R33 · FY2022 · NS
Enhanced gene delivery for CNS and sensory disorders$355,007
R01 · FY2022 · DC · contact PI
Enhanced gene delivery for CNS and sensory disorders$356,163
R01 · FY2021 · DC · contact PI
Gene therapy for tuberous sclerosis$420,000
R61 · FY2020 · NS
Enhanced gene delivery for CNS and sensory disorders$355,007
R01 · FY2020 · DC · contact PI
Gene therapy for tuberous sclerosis$420,000
R61 · FY2019 · NS
Enhanced gene delivery for CNS and sensory disorders$370,613
R01 · FY2019 · DC · contact PI
A hybrid microvesicle/virus vector for targeted gene transfer to the brain$209,888
R21 · FY2013 · NS · contact PI
A hybrid microvesicle/virus vector for targeted gene transfer to the brain$238,900
R21 · FY2012 · NS · contact PI